Etiopathogenesis of Nonalcoholic Steatohepatitis

By S. Chitturi, G. Farrell. Seminars in liver disease (Print), 2001

669 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (2003, neutral): “Fatty liver disease is a common finding in patients and various animal models with obesity, insulin resistance, diabetes, and dyslipidemia (60).”
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome (2002, methodology): “16 as follows: (1) a liver biopsy specimen showing steatosis, lobular inflammation, and hepatocellular degeneration, irrespective of the presence of fibrosis or Mallory bodies; (2) exclusion of patients with secondary causes of NASH; and (3) exclusion of other liver disorders (alcoholic liver diseas”
Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients (2001, background): “(3) No evidence of drug-induced liver disease, and no evidence of drug-induced liver injury on liver biopsy; (4) no long-term consumption of corticosteroids, amiodarone, tamoxifen, or tetracyclins; (5) seronegativity for hepatitis B surface antigen, hepatitis delta antigen (HDAg), hepatitis delta an”
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss (2022, background): “lipodystrophy or cachexia or intestinal bypass surgery) [13, 14].”